These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 16336336)

  • 1. Impact of overactive bladder symptoms on employment, social interactions and emotional well-being in six European countries.
    Irwin DE; Milsom I; Kopp Z; Abrams P; Cardozo L
    BJU Int; 2006 Jan; 97(1):96-100. PubMed ID: 16336336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study.
    Coyne KS; Sexton CC; Irwin DE; Kopp ZS; Kelleher CJ; Milsom I
    BJU Int; 2008 Jun; 101(11):1388-95. PubMed ID: 18454794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding the elements of overactive bladder: questions raised by the EPIC study.
    Irwin DE; Abrams P; Milsom I; Kopp Z; Reilly K;
    BJU Int; 2008 Jun; 101(11):1381-7. PubMed ID: 18336602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The economic impact of overactive bladder syndrome in six Western countries.
    Irwin DE; Mungapen L; Milsom I; Kopp Z; Reeves P; Kelleher C
    BJU Int; 2009 Jan; 103(2):202-9. PubMed ID: 19278532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of tolterodine ER on patient-reported outcomes in sexually active women with overactive bladder and urgency urinary incontinence.
    Rogers RG; Bachmann G; Scarpero H; Jumadilova Z; Sun F; Morrow JD; Guan Z; Bavendam T
    Curr Med Res Opin; 2009 Sep; 25(9):2159-65. PubMed ID: 19601704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What is the effect of overactive bladder symptoms on woman's quality of life during and after first pregnancy?
    Van Brummen HJ; Bruinse HW; Van de Pol G; Heintz AP; Van der Vaart CH
    BJU Int; 2006 Feb; 97(2):296-300. PubMed ID: 16430633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An epidemiological survey of overactive bladder symptoms in Japan.
    Homma Y; Yamaguchi O; Hayashi K;
    BJU Int; 2005 Dec; 96(9):1314-8. PubMed ID: 16287452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A longitudinal population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in women.
    Wennberg AL; Molander U; Fall M; Edlund C; Peeker R; Milsom I
    Eur Urol; 2009 Apr; 55(4):783-91. PubMed ID: 19157689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overactive bladder: prevalence, risk factors and relation to stress incontinence in middle-aged women.
    Teleman PM; Lidfeldt J; Nerbrand C; Samsioe G; Mattiasson A;
    BJOG; 2004 Jun; 111(6):600-4. PubMed ID: 15198789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of overactive bladder syndrome on the sexual quality of life in Korean young and middle aged women.
    Kim YH; Seo JT; Yoon H
    Int J Impot Res; 2005; 17(2):158-63. PubMed ID: 15510187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of overactive bladder on work productivity.
    Coyne KS; Sexton CC; Thompson CL; Clemens JQ; Chen CI; Bavendam T; Dmochowski R
    Urology; 2012 Jul; 80(1):97-103. PubMed ID: 22748868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence of overactive bladder.
    Milsom I; Stewart W; Thüroff J
    Am J Manag Care; 2000 Jul; 6(11 Suppl):S565-73. PubMed ID: 11183899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symptom bother and health-related quality of life outcomes following solifenacin treatment for overactive bladder: the VESIcare Open-Label Trial (VOLT).
    Garely AD; Kaufman JM; Sand PK; Smith N; Andoh M
    Clin Ther; 2006 Nov; 28(11):1935-46. PubMed ID: 17213014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of the overactive bladder syndrome by applying the International Continence Society definition.
    Temml C; Heidler S; Ponholzer A; Madersbacher S
    Eur Urol; 2005 Oct; 48(4):622-7. PubMed ID: 15964133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health-related consequences of overactive bladder.
    Wagner TH; Hu TW; Bentkover J; LeBlanc K; Stewart W; Corey R; Zhou Z; Hunt T
    Am J Manag Care; 2002 Dec; 8(19 Suppl):S598-607. PubMed ID: 12516954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solifenacin for overactive bladder with incontinence: symptom bother and health-related quality of life outcomes.
    Garely AD; Lucente V; Vapnek J; Smith N
    Ann Pharmacother; 2007 Mar; 41(3):391-8. PubMed ID: 17341526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defining overactive bladder: epidemiology and burden of disease.
    Tubaro A
    Urology; 2004 Dec; 64(6 Suppl 1):2-6. PubMed ID: 15621220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of bothersomeness and impact on quality of life of urinary incontinence in women in France, Germany, Spain and the UK.
    Papanicolaou S; Hunskaar S; Lose G; Sykes D
    BJU Int; 2005 Oct; 96(6):831-8. PubMed ID: 16153212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perceptions and behaviours of women with bladder control problems.
    Diokno AC; Sand PK; Macdiarmid S; Shah R; Armstrong RB
    Fam Pract; 2006 Oct; 23(5):568-77. PubMed ID: 16731545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of stress urinary incontinence and overactive bladder on quality of life in Thai women attending the urogynecology clinic.
    Wattanayingcharoenchai R; Manonai J; Vannatim N; Saritapirak S; Imsomboon C; Chittacharoen A
    J Med Assoc Thai; 2007 Jan; 90(1):26-31. PubMed ID: 17621729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.